Literature DB >> 18075987

[Monitoring cognitive characteristics in a population with hereditary cerebrovascular disease (CADASIL) in Colombia].

E Henao-Arboleda1, D C Aguirre-Acevedo, C Pacheco, O Yamile-Bocanegra, F Lopera.   

Abstract

INTRODUCTION: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary disease that affects small vessels and presents with vascular episodes, neuropsychiatric disorders, migraine and cognitive impairment. The cognitive disorder varies according to the time elapsed since onset. It is a condition with a subcortical origin related to executive dysfunction, slowing, attention-related disorders and memory disorders. AIM: To define the cognitive characteristics in two neuropsychological evaluations of carriers of Notch3 gene mutations as compared to non-carriers belonging to Colombian families with CADASIL. SUBJECTS AND METHODS: The study followed a longitudinal, retrospective design with 140 participants, including both carriers and non-carriers of the mutation. Cognitive performance was analysed by comparing the first and the last neuropsychological evaluation carried out on each subject at a four-year interval.
RESULTS: There were statistically significant differences (p < 0.05) between the two groups in the last evaluation, but only in some tests. Carriers and non-carriers did not display any significant changes between the first and the last evaluation.
CONCLUSIONS: No differences were found between both groups in the two evaluations. Cognitive impairment is not observed with the passage of time in carriers, probably owing to the fact that most of them were young, asymptomatic subjects. We believe that four years' follow-up is not enough time to observe a significant progression in the alterations affecting the cognitive functions in carriers of mutations in the Notch3 gene, which causes CADASIL. We also consider that more sensitive cognitive tools are needed to perform the neuropsychological evaluation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075987

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  2 in total

1.  The First Report of CADASIL in Peru: Olfactory Dysfunction on Initial Presentation.

Authors:  Anastasia Vishnevetsky; Miguel Inca-Martinez; Karina Milla-Neyra; Danny Moises Barrientos-Iman; Ivan Cornejo-Herrera; Carlos Cosentino; Mario Cornejo-Olivas
Journal:  eNeurologicalSci       Date:  2016-09-28

2.  Cognitive performance in asymptomatic carriers of mutations R1031C and R141C in CADASIL.

Authors:  Yesica Zuluaga-Castaño; David Andrés Montoya-Arenas; Lina Velilla; Carolina Ospina; Joseph F Arboleda-Velasquez; Yakeel T Quiroz; Francisco Lopera
Journal:  Int J Psychol Res (Medellin)       Date:  2018 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.